• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算的凝血领域的发现

Computationally Driven Discovery in Coagulation.

机构信息

Department of Mathematics, University of California Davis (K.G.L.).

Department of Mathematics and Computer Science, Coe College, Cedar Rapids, IA (M.T.S.).

出版信息

Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):79-86. doi: 10.1161/ATVBAHA.120.314648. Epub 2020 Oct 29.

DOI:10.1161/ATVBAHA.120.314648
PMID:33115272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7769924/
Abstract

Bleeding frequency and severity within clinical categories of hemophilia A are highly variable and the origin of this variation is unknown. Solving this mystery in coagulation requires the generation and analysis of large data sets comprised of experimental outputs or patient samples, both of which are subject to limited availability. In this review, we describe how a computationally driven approach bypasses such limitations by generating large synthetic patient data sets. These data sets were created with a mechanistic mathematical model, by varying the model inputs, clotting factor, and inhibitor concentrations, within normal physiological ranges. Specific mathematical metrics were chosen from the model output, used as a surrogate measure for bleeding severity, and statistically analyzed for further exploration and hypothesis generation. We highlight results from our recent study that employed this computationally driven approach to identify FV (factor V) as a key modifier of thrombin generation in mild to moderate hemophilia A, which was confirmed with complementary experimental assays. The mathematical model was used further to propose a potential mechanism for these observations whereby thrombin generation is rescued in FVIII-deficient plasma due to reduced substrate competition between FV and FVIII for FXa (activated factor X).

摘要

在 A 型血友病的临床分类中,出血频率和严重程度差异很大,其变异的起源尚不清楚。要解决凝血中的这个谜团,需要生成和分析由实验输出或患者样本组成的大型数据集,这两者都受到可用性有限的限制。在这篇综述中,我们描述了一种计算驱动的方法如何通过生成大型合成患者数据集来绕过这些限制。这些数据集是通过在正常生理范围内改变模型输入、凝血因子和抑制剂浓度,使用机械数学模型创建的。从模型输出中选择了特定的数学指标,作为出血严重程度的替代衡量标准,并进行了统计分析,以进一步探索和假设生成。我们重点介绍了我们最近的一项研究结果,该研究采用这种计算驱动的方法来确定 FV(因子 V)是轻度至中度 A 型血友病中凝血酶生成的关键调节剂,这一结果通过补充实验检测得到了证实。该数学模型进一步被用于提出一种潜在的机制,即由于 FV 和 FVIII 对 FXa(激活的因子 X)的底物竞争减少,FVIII 缺乏的血浆中的凝血酶生成得到挽救。

相似文献

1
Computationally Driven Discovery in Coagulation.基于计算的凝血领域的发现
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):79-86. doi: 10.1161/ATVBAHA.120.314648. Epub 2020 Oct 29.
2
A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.血流状态下凝血的数学模型确定因子V为甲型血友病中凝血酶生成的修饰因子。
J Thromb Haemost. 2020 Feb;18(2):306-317. doi: 10.1111/jth.14653. Epub 2019 Nov 1.
3
In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.原位生成的凝血酶是唯一能在凝血活酶激活的血浆中有效激活因子VIII和因子V的酶。
Blood. 1989 Aug 15;74(3):1021-4.
4
Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fab.严重甲型血友病患者激活蛋白 C 通路的调节:血栓调节蛋白和因子 V 稳定 Fab 的作用。
Haemophilia. 2017 Nov;23(6):941-947. doi: 10.1111/hae.13300. Epub 2017 Jul 27.
5
Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation.基于计算模型的因子 Xa 生成:评价凝血酶生成的另一个鉴别指标。
PLoS One. 2012;7(1):e29178. doi: 10.1371/journal.pone.0029178. Epub 2012 Jan 11.
6
Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.含有因子VIII C2结构域内Thr-2253-Gln-2270残基的合成肽的抗凝作用,该合成肽可选择性抑制因子Xa催化的因子VIII激活。
Br J Haematol. 2002 Mar;116(4):868-74. doi: 10.1046/j.0007-1048.2002.03360.x.
7
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.在流动模型中,组织因子在内皮细胞基质上引发的活化因子X和凝血酶形成:组织因子途径抑制剂的作用。
Blood. 1994 Aug 15;84(4):1132-42.
8
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).甲型血友病与因子V(莱顿)联合的体外分析。
Blood. 1997 Oct 15;90(8):3067-72.
9
Peptidomimetic inhibitors for activated protein C: implications for hemophilia management.活化蛋白C的拟肽抑制剂:对血友病治疗的意义。
J Thromb Haemost. 2006 Nov;4(11):2411-6. doi: 10.1111/j.1538-7836.2006.02226.x.
10
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.组织因子-因子VIIa-因子Xa复合物对因子VIII的选择性激活。
Blood. 2017 Oct 5;130(14):1661-1670. doi: 10.1182/blood-2017-02-767079. Epub 2017 Jul 20.

引用本文的文献

1
Coagulo-Net: Enhancing the mathematical modeling of blood coagulation using physics-informed neural networks.Coagulo-Net:使用物理信息神经网络增强血液凝固的数学建模。
Neural Netw. 2024 Dec;180:106732. doi: 10.1016/j.neunet.2024.106732. Epub 2024 Sep 19.
2
Investigating clot-flow interactions by integrating intravital imaging with in silico modeling for analysis of flow, transport, and hemodynamic forces.通过将活体成像与计算建模相结合来研究血栓流动相互作用,以分析流动、输运和血流动力学力。
Sci Rep. 2024 Jan 6;14(1):696. doi: 10.1038/s41598-023-49945-x.
3
Decoding thrombosis through code: a review of computational models.

本文引用的文献

1
A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.血流状态下凝血的数学模型确定因子V为甲型血友病中凝血酶生成的修饰因子。
J Thromb Haemost. 2020 Feb;18(2):306-317. doi: 10.1111/jth.14653. Epub 2019 Nov 1.
2
Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.低因子 V 水平可改善因子 V 和因子 VIII 联合缺乏症患者的出血倾向。
Blood. 2019 Nov 14;134(20):1745-1754. doi: 10.1182/blood.2018886069.
3
Kinetics of the coagulation cascade including the contact activation system: sensitivity analysis and model reduction.
解码血栓形成的密码:计算模型综述。
J Thromb Haemost. 2024 Jan;22(1):35-47. doi: 10.1016/j.jtha.2023.08.021. Epub 2023 Aug 30.
4
Critical evaluation of kinetic schemes for coagulation.对凝血动力学方案的批判性评估。
PLoS One. 2023 Aug 28;18(8):e0290531. doi: 10.1371/journal.pone.0290531. eCollection 2023.
5
von Willebrand factor unfolding mediates platelet deposition in a model of high-shear thrombosis.von Willebrand 因子展开介导高切变血栓形成模型中的血小板沉积。
Biophys J. 2022 Nov 1;121(21):4033-4047. doi: 10.1016/j.bpj.2022.09.040. Epub 2022 Oct 3.
6
Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and γ'-Fibrin.血栓形成的简化模型在流动下的敏感性分析:因子 IX、因子 XI 和 γ'纤维蛋白的作用。
PLoS One. 2021 Nov 23;16(11):e0260366. doi: 10.1371/journal.pone.0260366. eCollection 2021.
凝血级联反应动力学,包括接触激活系统:敏感性分析和模型降阶。
Biomech Model Mechanobiol. 2019 Aug;18(4):1139-1153. doi: 10.1007/s10237-019-01134-4. Epub 2019 Mar 21.
4
A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow.在流动条件下凝血和血小板沉积的数学模型的局部和全局敏感性分析。
PLoS One. 2018 Jul 26;13(7):e0200917. doi: 10.1371/journal.pone.0200917. eCollection 2018.
5
Modeling thrombosis in silico: Frontiers, challenges, unresolved problems and milestones.计算机模拟血栓形成:前沿、挑战、未解决的问题和里程碑。
Phys Life Rev. 2018 Nov;26-27:57-95. doi: 10.1016/j.plrev.2018.02.005. Epub 2018 Mar 5.
6
Platelets and hemostasis: a new perspective on an old subject.血小板与止血:一个古老主题的新视角。
Blood Adv. 2016 Nov 22;1(1):5-9. doi: 10.1182/bloodadvances.2016000059. eCollection 2016 Nov 29.
7
Modeling thrombus formation and growth.模拟血栓形成与生长。
Biotechnol Bioeng. 2017 Oct;114(10):2154-2172. doi: 10.1002/bit.26343. Epub 2017 Jun 26.
8
Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.组织因子与外源性因子XIa在启动凝血过程中的协同作用。
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2334-2345. doi: 10.1161/ATVBAHA.116.308186. Epub 2016 Oct 27.
9
Blood flow and mass transfer regulation of coagulation.凝血的血流与质量传递调节
Blood Rev. 2016 Sep;30(5):357-68. doi: 10.1016/j.blre.2016.04.004. Epub 2016 Apr 29.
10
Systems Analysis of Thrombus Formation.血栓形成的系统分析
Circ Res. 2016 Apr 29;118(9):1348-62. doi: 10.1161/CIRCRESAHA.115.306824.